• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mechanism of Initiation and Progression of Glomerular Sclerosis and its Prevention in Hypertensive Kidneys

Research Project

Project/Area Number 10670998
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionShimane Medical University

Principal Investigator

TAKABATAKE Toshikazu  Faculty of Medicine, Shimane Medical University, Professor, 医学部, 教授 (60111762)

Co-Investigator(Kenkyū-buntansha) KAWABATA Masahiko  Faculty of Medicine, Shimane Medical University, Assistant Professor, 医学部, 講師 (70291466)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 1999: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1998: ¥1,800,000 (Direct Cost: ¥1,800,000)
Keywordshypertension / microcirculation / glomerular sclerosis / kidney function / intraglomerular pressure / vasoactive substaces / nephron / rat
Research Abstract

Glomerular hemodynamics and tubuloglomerular feedback (TGF) mechanism were evaluated in anesthetized 9-25-week-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY).
Micropuncture experiments revealed that the maximal reduction of proximal stop-flow pressure (SEP), an index of intraglomerular pressure (Pgc), induced by loop of Henle perfusion was significantly larger in SHR than in WKY at 9-10 week old (33 vs. 22% of SFP at zero perfusion), indicating the hyperactivity of TGF in SHR. Systemic blood pressure (SBP) was higher, renal vascular resistance (RVR) was greater, and renal plasma flow (RPF) was less in SHR than in WKY. At 14-16 week old, however, the difference of SFP reduction was not observed (28 vs. 28%). SFP at zero perfusion was comparable among 9-10, 14-16, and 23-25-week-old SHR. Adenosine A1 receptor antagonist (FK838, I.v.) suppressed TGF and increased SFP at zero perfusion in SHR, thus induced an upwards shift of the TGF curve. FK838 increased GFR, RPF, and FENa, while SBP remained unaltered. Adrenomedullin (I.v.) suppressed TGF in SHR to the level in WKY ; the SFP at zero perfusion was unchanged and the tubular flow rate at the steady state increased, indicating a rightwards shift of the TGF curve. SBP and RVR were decreased, GFR unchanged, and RPF and FENa increased by adrenomedullin.
In conclusion, TGF is activated in SHR at 9-10 week old, and Pgc remains normal in 9-25-week-old SHR. A1 antagonist or adrenomedullin suppresses TGF. The former induces the glomerular hypertension and hyperfiltration through the afferent arteriolar vasodilatation. The latter, however, keeps Pgc normal through both afferent and efferent vasodilatation. Adrenomedullin normalizes TGF, induces natriuresis, and lowers SBP, and thereby may prevent the initiation and/or the progression of the glomerular sclerosis in SHR.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] M. Kawabata, T. Ogawa, T. Takabatake: "Effects of lemildipine, a new calcium channel blocker, or renal microcirculation in SHR"Hypertension Research. 21. 121-126 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kawabata, T. Ogawa, T. Takabatake: "Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors"Kidney International. 54 (Suppl 67). S228-S230 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kawabata, T. Ogawa, W-H. Han, T. Takabatake: "Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury"Clinical and Experimental Pharmacology and Physiology. 26. 674-679 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kawabata, T. Ogawa, T. Takabatake: "Effects of lemildipine, a new calcium channel blocker, on renal microcirculation in SHR"Hypertension Research. 21. 121-126 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kawabata, T. Ogawa, T. Takabatake: "Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors"Kidney International. 54 (Suppl 67). S-228-S-230 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kawabata, T. Ogawa, W-H. Han, T. Takabatake: "Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury"Clinical and Experimental Pharmacology and Physiology. 26. 674-679 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M.Kawabata,T.Ogawa,W・H.Han,T.Takabatake: "Rental effects of efonidipine hydrochloride,a new calcium antagonist,in spontaneously hypertensive rats with glomerular injury."Clinical and Experimental Pharmacology and Physiology.. 26. 674-679 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] M.Kawabata, T.Ogawa, T.Takabatake: "Effects of lemildipine,a new calcium channel blocker,on renal microcirculation in SHR." Hypertension Research. 21. 121-126 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi